Peter Attia· MD
the patient was a young woman with acute myeloid leukemia and she was very strange because she presented with a very large spleen as well so we knew that she must have had a prior myeloproliferative milo dysplastic some sort of a precursor that led up to the acute leukemia so right there and then i started having discussions with my teachers that how much easier it would be to study a liquid tumor because cells are already in suspension and you can go in and sample them so many times instead of trying to study a solid tumor which is a mass that you can only remove once next time it appears it wouldn't even be the same tumor and you don't have the luxury of accessing the tumor before during and after treatment